"We're happy to continue supporting DTRA by providing reliable, innovative solutions that address the complexities of modern threats to help keep America and its allies safe and strong.

and resources to allow partner nations in Eastern Europe to address existing and emerging security risks. The company will provide DTRA with program management, equipment procurement and delivery ...

CHATHAM, N.J., Nov. 13, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: TNXP) (Tonix or the Company), a fully-integrated biopharmaceutical ...

"We're happy to continue supporting DTRA by providing reliable, innovative solutions that address the complexities of modern threats to help keep America and its allies safe and strong. "We are proud ...

Submitted New Drug Application (NDA) to FDA for TNX-102 SL for fibromyalgia based on two statistically significant Phase 3 studiesGranted Fast ...

Under this task order, Parsons will provide expertise, training, and resources to allow partner nations in Eastern Europe to address existing and emerging security risks. The company will provide DTRA ...

Tonix Pharmaceuticals (NASDAQ: TNXP) through its subsidiary Tonix Medicines, has introduced two fast-acting migraine treatments, Zembrace® SymTouch ...

Soligenix, Inc. (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical ...